The Lupus Research Alliance has awarded grants of up to $600,000 each to seven scientists…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Women who were victims of physical or emotional abuse during childhood are at a higher risk of developing…
Psychosis is a rare manifestation of systemic lupus erythematosus (SLE) that generally appears early, in the year…
Xencor announced top-line results from its Phase 2 clinical trial testing the candidate antibody therapy …
Smoking was found to be associated with an increased risk of systemic lupus erythematosus (SLE)…
IFN-alpha Kinoid, an investigational vaccine by Neovacs, has a favorable safety profile and showed encouraging…
Lower testosterone levels might be the reason behind why women are at a higher risk than men of…
A new mechanism that helps to maintain immune self-tolerance and prevent autoimmune diseases was discovered using human cells…
Infection with the Epstein-Barr virus (EBV) that causes mononucleosis can increase a person’s risk of developing any of…
A Phase 2 clinical trial testing a Corbus Pharmaceuticals’ synthetic cannabinoid derivative – lenabasum (JBT-101) – for…